Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
452
Employees452
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
452
Employees452

AXGN Key Statistics

Market cap
1.08B
Market cap1.08B
Price-Earnings ratio
-485.10
Price-Earnings ratio-485.10
Dividend yield
Dividend yield
Average volume
1.13M
Average volume1.13M
High today
$24.25
High today$24.25
Low today
$23.22
Low today$23.22
Open price
$23.86
Open price$23.86
Volume
781.33K
Volume781.33K
52 Week high
$24.25
52 Week high$24.25
52 Week low
$9.22
52 Week low$9.22

Stock Snapshot

With a market cap of 1.08B, Axogen(AXGN) trades at $23.26. The stock has a price-to-earnings ratio of -485.10.

On 2025-11-05, Axogen(AXGN) stock traded between a low of $23.22 and a high of $24.25. Shares are currently priced at $23.26, which is +0.2% above the low and -4.1% below the high.

Axogen(AXGN) shares are trading with a volume of 781.33K, against a daily average of 1.13M.

In the last year, Axogen(AXGN) shares hit a 52-week high of $24.25 and a 52-week low of $9.22.

In the last year, Axogen(AXGN) shares hit a 52-week high of $24.25 and a 52-week low of $9.22.

AXGN News

Simply Wall St 1d
Axogen, Inc. Looks Just Right With A 30% Price Jump

Axogen, Inc. ( ) shares have continued their recent momentum with a 30% gain in the last month alone. The last 30 days bring the annual gain to a very sharp 64%...

Axogen, Inc. Looks Just Right With A 30% Price Jump
Simply Wall St 4d
Why Axogen Is Up 22.3% After Returning to Profitability and Raising 2025 Guidance

Axogen, Inc. recently reported third quarter 2025 results, highlighting sales of US$60.08 million, net income of US$0.71 million, and raised its full-year 2025...

Why Axogen Is Up 22.3% After Returning to Profitability and Raising 2025 Guidance
TipRanks 6d
AxoGen price target raised to $26 from $25 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on AxoGen (AXGN) to $26 from $25 and keeps a Buy rating on the shares. The company reported a Q3 beat and upped i...

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

More AXGN News

TipRanks 6d
AxoGen’s Strong Financial Performance and Strategic Advancements Justify Buy Rating

Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on AxoGen, boosting the price target to $26.00. Elevate Your Investing Strategy: Take advantage of Ti...

TipRanks 7d
Axogen Reports Strong Q3 2025 Results, Raises Guidance

AxoGen ( (AXGN) ) has released its Q3 earnings. Here is a breakdown of the information AxoGen presented to its investors. Elevate Your Investing Strategy: Tak...

TipRanks 7d
AxoGen’s Earnings Call Highlights Robust Growth and Strategic Progress

AxoGen ((AXGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.